We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+17.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$384M
Cap. Flow
+$115M
Cap. Flow %
5.09%
Top 10 Hldgs %
22.4%
Holding
443
New
33
Increased
160
Reduced
64
Closed
38

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$39.7M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$14.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.1M
4
WLK icon
Westlake Corp
WLK
+$8.6M
5
BKNG icon
Booking.com
BKNG
+$6.85M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.3M
2
CELG
Celgene Corp
CELG
+$20.8M
3
TIF
Tiffany & Co.
TIF
+$8.44M
4
SOXX icon
iShares Semiconductor ETF
SOXX
+$7.14M
5
ROP icon
Roper Technologies
ROP
+$5.77M

Sector Composition

Rank Sector Weight
1 Healthcare 30.75%
2 Technology 20.83%
3 Consumer Discretionary 14.53%
4 Financials 9.34%
5 Miscellaneous 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
301
Pacira BioSciences
PCRX
$960M
$642K 0.03%
14,400
– –
AVY icon
302
Avery Dennison
AVY
$13B
$641K 0.03%
4,870
– –
CTSH icon
303
Cognizant
CTSH
$28.5B
$622K 0.03%
+10,000
New +$618K
WRB icon
304
W.R. Berkley
WRB
$26.5B
$617K 0.03%
20,250
– –
TRV icon
305
Travelers Companies
TRV
$78.8B
$616K 0.03%
4,500
– –
VFC icon
306
VF Corp
VFC
$5B
$610K 0.03%
6,100
+800
+15% +$71.7K
ADI icon
307
Analog Devices
ADI
$175B
$597K 0.03%
5,000
– –
BAP icon
308
Credicorp
BAP
$29.6B
$595K 0.03%
2,762
– –
TTWO icon
309
Take-Two Interactive
TTWO
$39.6B
$559K 0.02%
4,522
+128
+3% +$15.6K
VLO icon
310
Valero Energy
VLO
$114B
$559K 0.02%
6,000
– –
PTLA
311
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$559K 0.02%
22,300
– –
CLR
312
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$543K 0.02%
16,000
– –
RGNX icon
313
Regenxbio
RGNX
$525M
$527K 0.02%
13,000
– –
TJX icon
314
TJX Companies
TJX
$137B
$517K 0.02%
+8,500
New +$503K
TVTX icon
315
Travere Therapeutics
TVTX
$5.89B
$512K 0.02%
35,600
– –
TSN icon
316
Tyson Foods
TSN
$18.5B
$503K 0.02%
5,500
+1,600
+41% +$138K
TDC icon
317
Teradata
TDC
$2.73B
$492K 0.02%
18,500
+500
+3% +$13.9K
ORA icon
318
Ormat Technologies
ORA
$5.61B
$438K 0.02%
5,880
– –
AXTA icon
319
Axalta
AXTA
$7.12B
$409K 0.02%
13,500
+2,500
+23% +$73.7K
HDS
320
DELISTED
HD Supply Holdings, Inc.
HDS
$405K 0.02%
10,000
– –
Y
321
DELISTED
Alleghany Corp
Y
$397K 0.02%
500
– –
EDIT icon
322
Editas Medicine
EDIT
$404M
$396K 0.02%
13,000
– –
ENTA icon
323
Enanta Pharmaceuticals
ENTA
$358M
$388K 0.02%
6,200
– –
AFG icon
324
American Financial Group
AFG
$11.9B
$382K 0.02%
3,500
– –
NEM icon
325
Newmont
NEM
$131B
$356K 0.02%
8,130
-656
-7% -$25.6K
11 12
13
14 15

Similar funds

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
WI
WealthNavi Inc Shinagawa-Ku, Tokyo, Japan $12.8B AUM 19.73% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Erste Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Erste Asset Management held 443 positions worth $2.26B, up 20% from $1.88B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $115M of net new capital in Q4 2019, opening 33 new positions and adding to 160 existing holdings. Its largest new stake was Westlake Corp: 128,000 shares worth $8.83M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $26.3M trimmed.

  • Erste Asset Management's largest Q4 2019 buy was Westlake Corp: 128,000 shares worth $8.83M.
  • Erste Asset Management added most to Biogen in Q4 2019, an estimated $39.7M increase.
  • Erste Asset Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $26.3M.
  • Erste Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
  • Erste Asset Management's ten largest holdings make up 22% of its $2.26B portfolio in Q4 2019.
  • Erste Asset Management opened 33 new positions and closed 38 in Q4 2019.
  • Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $2.26B.

Based on Erste Asset Management's 13F filing for Q4 2019, filed 22 Nov 2024.